Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology Group trial (P9962).
about
The role of pH and ring-opening hydrolysis kinetics on liposomal release of topotecan.Topoisomerase 1 inhibition reversibly impairs synaptic function.A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: a Pediatric Brain Tumor Consortium study.Pilot study assessing a seven-day continuous intrathecal topotecan infusion for recurrent or progressive leptomeningeal metastatic cancer.
P2860
Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology Group trial (P9962).
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Phase 2 clinical trial of intr ...... Oncology Group trial (P9962).
@ast
Phase 2 clinical trial of intr ...... Oncology Group trial (P9962).
@en
type
label
Phase 2 clinical trial of intr ...... Oncology Group trial (P9962).
@ast
Phase 2 clinical trial of intr ...... Oncology Group trial (P9962).
@en
prefLabel
Phase 2 clinical trial of intr ...... Oncology Group trial (P9962).
@ast
Phase 2 clinical trial of intr ...... Oncology Group trial (P9962).
@en
P2093
P2860
P356
P1476
Phase 2 clinical trial of intr ...... Oncology Group trial (P9962).
@en
P2093
Ashish Mark Ingle
Mark Krailo
Peter C Adamson
Samara L Poplack Potter
Stacey Berg
P2860
P304
P356
10.1002/PBC.23317
P577
2011-09-09T00:00:00Z